Recent Updates
Recently added Catalysts
BWAY Positive Sentiment

Deep Transcranial Magnetic Stimulation in combination with symptoms provocation: An effective treatment in patients with treatment-resistant Body Dysmorphic Disorder?

Key Takeaway: This article discusses a case series involving three patients with treatment-resistant Body Dysmorphic Disorder (BDD) who were treated with deep Transcranial Magnetic Stimulation (dTMS) combined with symptom provocation. The treatment resulted in a reduction of symptoms for all patients. These findings highlight the potential of dTMS as a viable option for BDD, though further research is needed.
Price reaction · baseline $2.425 (2023-11-22T14:39:00.000Z) · hit during market hours · 2 other BWAY headline(s) in the window, move may be shared
day 0 close
+13.6%
day 1
+20.2%
day 3 · peak
+27.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • dTMS shows promise as a treatment for resistant BDD patients.
  • All three patients experienced a decrease in symptom severity.
  • Combining dTMS with symptom provocation may enhance treatment efficacy.

Full Press Release Details

Summary:

Body Dysmorphic Disorder (BDD) involves an excessive preoccupation with a perceived physical flaw, leading to impaired functioning. There is currently no FDA-approved treatment for BDD, and many patients do not respond to standard therapies. Neuromodulation, particularly deep Transcranial Magnetic Stimulation (dTMS), emerges as a significant option for treating resistant patients within the obsessive-compulsive spectrum.
While no prior studies have explored the use of dTMS in BDD, this case series presents three patients with treatment-resistant BDD who underwent dTMS in combination with symptom provocation, a cognitive-behavioral therapy technique. The severity of symptoms decreased in all three patients following the treatment.
These initial findings suggest that dTMS combined with symptom provocation could be an effective approach for individuals with treatment-resistant BDD. However, further prospective studies are required to validate these observations.

Frequently Asked Questions

What is Body Dysmorphic Disorder?

Body Dysmorphic Disorder (BDD) is characterized by an excessive focus on perceived physical flaws.

What treatment was used in the study?

The study used deep Transcranial Magnetic Stimulation (dTMS) combined with symptom provocation.

How many patients were involved in the case series?

The case series involved three patients with treatment-resistant BDD.

What were the results of the treatment?

All three patients experienced a decrease in the severity of their symptoms.

Is dTMS approved for treating BDD?

Currently, there is no FDA-approved treatment specifically for Body Dysmorphic Disorder.

Last updated: Nov 22, 2023